Eva Petkova - Publications

Affiliations: 
Columbia University, New York, NY 
Area:
Biostatistics Biology

67 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Park H, Petkova E, Tarpey T, Ogden RT. A single-index model with multiple-links. Journal of Statistical Planning and Inference. 205: 115-128. PMID 32831459 DOI: 10.1016/J.Jspi.2019.05.008  0.339
2020 Park H, Petkova E, Tarpey T, Ogden RT. A sparse additive model for treatment effect-modifier selection. Biostatistics (Oxford, England). PMID 32808656 DOI: 10.1093/Biostatistics/Kxaa032  0.32
2020 Park H, Petkova E, Tarpey T, Ogden RT. A constrained single-index regression for estimating interactions between a treatment and covariates. Biometrics. PMID 32573759 DOI: 10.1111/Biom.13320  0.335
2019 Jiang B, Petkova E, Tarpey T, Ogden RT. A Bayesian Approach to Joint Modeling of Matrix-valued Imaging Data and Treatment Outcome with Applications to Depression Studies. Biometrics. PMID 31529701 DOI: 10.1111/Biom.13151  0.313
2018 Ciarleglio A, Petkova E, Ogden T, Tarpey T. Constructing treatment decision rules based on scalar and functional predictors when moderators of treatment effect are unknown. Journal of the Royal Statistical Society. Series C, Applied Statistics. 67: 1331-1356. PMID 30546161 DOI: 10.1111/Rssc.12278  0.365
2018 Yang J, Zhang M, Ahn H, Zhang Q, Jin TB, Li IA, Nemesure M, Joshi N, Jiang H, Miller JM, Ogden RT, Petkova E, Milak MS, Sublette ME, Sullivan GM, et al. Development and evaluation of a multimodal marker of major depressive disorder. Human Brain Mapping. PMID 30113112 DOI: 10.1002/Hbm.24282  0.352
2018 Bartlett EA, DeLorenzo C, Sharma P, Yang J, Zhang M, Petkova E, Weissman M, McGrath PJ, Fava M, Ogden RT, Kurian BT, Malchow A, Cooper CM, Trombello JM, McInnis M, et al. Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29955151 DOI: 10.1038/S41386-018-0122-9  0.375
2018 Kayser J, Tenke CE, Petkova E, Wong LY, Wickramaratne P, Alschuler DM, Alvarenga JE, Abraham K, Pechtel P, Webb CA, Dillon DG, Deldin P, Cooper C, Trombello J, McGrath P, et al. S95. Loudness Dependency of Auditory Evoked Potentials (LDAEP) as a Differential Predictor of Antidepressant Treatment Response in Major Depressive Disorder (MDD): Results From the Sertraline/Placebo-Controlled EMBARC Study Biological Psychiatry. 83: S383-S384. DOI: 10.1016/J.Biopsych.2018.02.986  0.361
2018 Bartlett E, DeLorenzo C, Sharma P, Yang J, Zhang M, Petkova E, Weissman M, McGrath P, Fava M, Ogden T, Kurian B, Malchow A, Cooper C, Trombello J, McInnis M, et al. 176. Evidence of Differential Changes in Cortical Thickness and Volume Between SSRI and Placebo Treated Patients With Major Depressive Disorder Biological Psychiatry. 83: S71. DOI: 10.1016/J.Biopsych.2018.02.194  0.34
2017 Jiang B, Petkova E, Tarpey T, Ogden RT. LATENT CLASS MODELING USING MATRIX COVARIATES WITH APPLICATION TO IDENTIFYING EARLY PLACEBO RESPONDERS BASED ON EEG SIGNALS. The Annals of Applied Statistics. 11: 1513-1536. PMID 29152032 DOI: 10.1214/17-Aoas1044  0.341
2017 Petkova E, Ogden RT, Tarpey T, Ciarleglio A, Jiang B, Su Z, Carmody T, Adams P, Kraemer HC, Grannemann BD, Oquendo MA, Parsey R, Weissman M, McGrath PJ, Fava M, et al. Statistical Analysis Plan for Stage 1 EMBARC (Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care) Study. Contemporary Clinical Trials Communications. 6: 22-30. PMID 28670629 DOI: 10.1016/J.Conctc.2017.02.007  0.365
2017 Markowitz JC, Neria Y, Lovell K, Van Meter PE, Petkova E. History of sexual trauma moderates psychotherapy outcome for posttraumatic stress disorder. Depression and Anxiety. PMID 28376282 DOI: 10.1002/Da.22619  0.302
2017 Alvarez-Fernandez S, Brown HR, Zhao Y, Raithel JA, Bishop SL, Kern SB, Lord C, Petkova E, Di Martino A. Perceived social support in adults with autism spectrum disorder and attention-deficit/hyperactivity disorder. Autism Research : Official Journal of the International Society For Autism Research. PMID 28256072 DOI: 10.1002/Aur.1735  0.324
2016 Cloitre M, Petkova E, Su Z, Weiss B. Patient characteristics as a moderator of post-traumatic stress disorder treatment outcome: combining symptom burden and strengths. Bjpsych Open. 2: 101-106. PMID 27703762 DOI: 10.1192/Bjpo.Bp.115.000745  0.334
2016 Petkova E, Tarpey T, Su Z, Ogden RT. Generated effect modifiers (GEM's) in randomized clinical trials. Biostatistics (Oxford, England). PMID 27465235 DOI: 10.1093/Biostatistics/Kxw035  0.363
2016 Bruno D, Ciarleglio A, Grothe MJ, Nierenberg J, Bachman AH, Teipel SJ, Petkova E, Ardekani BA, Pomara N. Hippocampal volume and integrity as predictors of cognitive decline in intact elderly. Neuroreport. PMID 27306593 DOI: 10.1097/Wnr.0000000000000629  0.31
2016 Trivedi MH, McGrath PJ, Fava M, Parsey RV, Kurian BT, Phillips ML, Oquendo MA, Bruder G, Pizzagalli D, Toups M, Cooper C, Adams P, Weyandt S, Morris DW, Grannemann BD, ... ... Petkova E, et al. Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design. Journal of Psychiatric Research. 78: 11-23. PMID 27038550 DOI: 10.1016/J.Jpsychires.2016.03.001  0.403
2016 Masia Warner C, Colognori D, Brice C, Herzig K, Mufson L, Lynch C, Reiss PT, Petkova E, Fox J, Moceri DC, Ryan J, Klein RG. Can school counselors deliver cognitive-behavioral treatment for social anxiety effectively? A randomized controlled trial. Journal of Child Psychology and Psychiatry, and Allied Disciplines. PMID 27002215 DOI: 10.1111/Jcpp.12550  0.321
2016 Tarpey T, Petkova E, Zhu L. Stratified Psychiatry via Convexity-Based Clustering with Applications Towards Moderator Analysis. Statistics and Its Interface. 9: 255-266. PMID 26998190 DOI: 10.4310/Sii.2016.V9.N3.A1  0.36
2015 Markowitz JC, Meehan KB, Petkova E, Zhao Y, Van Meter PE, Neria Y, Pessin H, Nazia Y. Treatment preferences of psychotherapy patients with chronic PTSD. The Journal of Clinical Psychiatry. PMID 26115532 DOI: 10.4088/Jcp.14M09640  0.377
2015 Ciarleglio A, Petkova E, Ogden RT, Tarpey T. Treatment decisions based on scalar and functional baseline covariates. Biometrics. PMID 26111145 DOI: 10.1111/Biom.12346  0.378
2015 Markowitz JC, Petkova E, Neria Y, Van Meter PE, Zhao Y, Hembree E, Lovell K, Biyanova T, Marshall RD. Is Exposure Necessary? A Randomized Clinical Trial of Interpersonal Psychotherapy for PTSD. The American Journal of Psychiatry. 172: 430-40. PMID 25677355 DOI: 10.1176/Appi.Ajp.2014.14070908  0.315
2015 Pomara N, Lee SH, Bruno D, Silber T, Greenblatt DJ, Petkova E, Sidtis JJ. Adverse performance effects of acute lorazepam administration in elderly long-term users: pharmacokinetic and clinical predictors. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 56: 129-35. PMID 25195839 DOI: 10.1016/J.Pnpbp.2014.08.014  0.358
2014 Cloitre M, Henn-Haase C, Herman JL, Jackson C, Kaslow N, Klein C, Mendelsohn M, Petkova E. A multi-site single-blind clinical study to compare the effects of STAIR Narrative Therapy to treatment as usual among women with PTSD in public sector mental health settings: study protocol for a randomized controlled trial. Trials. 15: 197. PMID 24886235 DOI: 10.1186/1745-6215-15-197  0.342
2013 Samar SM, Moyano MB, Braña-Berríos M, Irazoqui G, Matos A, Kichic R, Gellatly R, Ibanez-Gomez L, Zwilling AL, Petkova E, Coffey BJ. Children and adolescents with Tourette's disorder in the USA versus Argentina: behavioral differences may reflect cultural factors. European Child & Adolescent Psychiatry. 22: 701-7. PMID 23568420 DOI: 10.1007/S00787-013-0406-X  0.367
2013 Petkova E, Tarpey T, Huang L, Deng L. Interpreting meta-regression: application to recent controversies in antidepressants' efficacy. Statistics in Medicine. 32: 2875-92. PMID 23440635 DOI: 10.1002/Sim.5766  0.325
2013 Abikoff H, Gallagher R, Wells KC, Murray DW, Huang L, Lu F, Petkova E. Remediating organizational functioning in children with ADHD: immediate and long-term effects from a randomized controlled trial. Journal of Consulting and Clinical Psychology. 81: 113-28. PMID 22889336 DOI: 10.1037/A0029648  0.319
2012 Fallon BA, Petkova E, Keilp JG, Britton CB. A reappraisal of the u.s. Clinical trials of post-treatment lyme disease syndrome. The Open Neurology Journal. 6: 79-87. PMID 23091568 DOI: 10.2174/1874205X01206010079  0.347
2012 Gabbay V, Babb JS, Klein RG, Panzer AM, Katz Y, Alonso CM, Petkova E, Wang J, Coffey BJ. A double-blind, placebo-controlled trial of ω-3 fatty acids in Tourette's disorder. Pediatrics. 129: e1493-500. PMID 22585765 DOI: 10.1542/Peds.2011-3384  0.326
2012 Cloitre M, Petkova E, Wang J, Lu Lassell F. An examination of the influence of a sequential treatment on the course and impact of dissociation among women with PTSD related to childhood abuse. Depression and Anxiety. 29: 709-17. PMID 22550033 DOI: 10.1002/Da.21920  0.303
2012 Lord C, Petkova E, Hus V, Gan W, Lu F, Martin DM, Ousley O, Guy L, Bernier R, Gerdts J, Algermissen M, Whitaker A, Sutcliffe JS, Warren Z, Klin A, et al. A multisite study of the clinical diagnosis of different autism spectrum disorders. Archives of General Psychiatry. 69: 306-13. PMID 22065253 DOI: 10.1001/Archgenpsychiatry.2011.148  0.324
2011 Reigada LC, Bruzzese JM, Benkov KJ, Levy J, Waxman AR, Petkova E, Warner CM. Illness-specific anxiety: implications for functioning and utilization of medical services in adolescents with inflammatory bowel disease. Journal For Specialists in Pediatric Nursing : Jspn. 16: 207-15. PMID 21702881 DOI: 10.1111/J.1744-6155.2011.00292.X  0.305
2011 Warner CM, Colognori D, Kim RE, Reigada LC, Klein RG, Browner-Elhanan KJ, Saborsky A, Petkova E, Reiss P, Chhabra M, McFarlane-Ferreira YB, Phoon CK, Pittman N, Benkov K. Cognitive-behavioral treatment of persistent functional somatic complaints and pediatric anxiety: an initial controlled trial. Depression and Anxiety. 28: 551-9. PMID 21681863 DOI: 10.1002/Da.20821  0.358
2010 Tarpey T, Petkova E, Lu Y, Govindarajulu U. Optimal Partitioning for Linear Mixed Effects Models: Applications to Identifying Placebo Responders. Journal of the American Statistical Association. 105: 968-977. PMID 21494314 DOI: 10.1198/Jasa.2010.Ap08713  0.335
2010 Hellerstein DJ, Skodol AE, Petkova E, Xie H, Markowitz JC, Yen S, Gunderson J, Grilo C, Daversa MT, McGlashan TH. The impact of comorbid dysthymic disorder on outcome in personality disorders. Comprehensive Psychiatry. 51: 449-57. PMID 20728000 DOI: 10.1016/J.Comppsych.2009.11.002  0.323
2010 Cloitre M, Stovall-McClough KC, Nooner K, Zorbas P, Cherry S, Jackson CL, Gan W, Petkova E. Treatment for PTSD related to childhood abuse: a randomized controlled trial. The American Journal of Psychiatry. 167: 915-24. PMID 20595411 DOI: 10.1176/Appi.Ajp.2010.09081247  0.325
2010 Tarpey T, Petkova E. Principal Point Classification: Applications to Differentiating Drug and Placebo Responses in Longitudinal Studies. Journal of Statistical Planning and Inference. 140: 539-550. PMID 20563220 DOI: 10.1016/J.Jspi.2009.07.030  0.319
2009 Petkova E, Tarpey T, Govindarajulu U. Predicting potential placebo effect in drug treated subjects. The International Journal of Biostatistics. 5: Article 23. PMID 21556319 DOI: 10.2202/1557-4679.1152  0.319
2009 Petkova E, Tarpey T. Partitioning of Functional Data for Understanding Heterogeneity in Psychiatric Conditions. Statistics and Its Interface. 2: 413-424. PMID 20336166 DOI: 10.4310/Sii.2009.V2.N4.A3  0.368
2008 Ross S, Fallon BA, Petkova E, Feinstein S, Liebowitz MR. Long-term follow-up study of patients with refractory obsessive-compulsive disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 20: 450-7. PMID 19196930 DOI: 10.1176/Jnp.2008.20.4.450  0.366
2008 Fallon BA, Petkova E, Skritskaya N, Sanchez-Lacay A, Schneier F, Vermes D, Cheng J, Liebowitz MR. A double-masked, placebo-controlled study of fluoxetine for hypochondriasis. Journal of Clinical Psychopharmacology. 28: 638-45. PMID 19011432 DOI: 10.1097/Jcp.0B013E31818D21Cf  0.6
2008 Di Martino A, Ghaffari M, Curchack J, Reiss P, Hyde C, Vannucci M, Petkova E, Klein DF, Castellanos FX. Decomposing intra-subject variability in children with attention-deficit/hyperactivity disorder. Biological Psychiatry. 64: 607-14. PMID 18423424 DOI: 10.1016/J.Biopsych.2008.03.008  0.312
2008 Simpson HB, Foa EB, Liebowitz MR, Ledley DR, Huppert JD, Cahill S, Vermes D, Schmidt AB, Hembree E, Franklin M, Campeas R, Hahn CG, Petkova E. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. The American Journal of Psychiatry. 165: 621-30. PMID 18316422 DOI: 10.1176/Appi.Ajp.2007.07091440  0.36
2008 Lipsitz JD, Gur M, Vermes D, Petkova E, Cheng J, Miller N, Laino J, Liebowitz MR, Fyer AJ. A randomized trial of interpersonal therapy versus supportive therapy for social anxiety disorder. Depression and Anxiety. 25: 542-53. PMID 17941096 DOI: 10.1002/Da.20364  0.576
2008 Fallon BA, Keilp JG, Corbera KM, Petkova E, Britton CB, Dwyer E, Slavov I, Cheng J, Dobkin J, Nelson DR, Sackeim HA. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 70: 992-1003. PMID 17928580 DOI: 10.1212/01.Wnl.0000284604.61160.2D  0.564
2008 Simpson HB, Petkova E, Cheng J, Huppert J, Foa E, Liebowitz MR. Statistical choices can affect inferences about treatment efficacy: a case study from obsessive-compulsive disorder research. Journal of Psychiatric Research. 42: 631-8. PMID 17892885 DOI: 10.1016/J.Jpsychires.2007.07.012  0.595
2007 Devlin MJ, Goldfein JA, Petkova E, Liu L, Walsh BT. Cognitive behavioral therapy and fluoxetine for binge eating disorder: two-year follow-up. Obesity (Silver Spring, Md.). 15: 1702-9. PMID 17636088 DOI: 10.1038/Oby.2007.203  0.32
2007 Covey LS, Glassman AH, Jiang H, Fried J, Masmela J, LoDuca C, Petkova E, Rodriguez K. A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse. Addiction (Abingdon, England). 102: 1292-302. PMID 17624979 DOI: 10.1111/J.1360-0443.2007.01887.X  0.301
2007 Markowitz JC, Skodol AE, Petkova E, Cheng J, Sanislow CA, Grilo CM, Gunderson JG, McGlashan TH. Longitudinal effects of personality disorders on psychosocial functioning of patients with major depressive disorder. The Journal of Clinical Psychiatry. 68: 186-93. PMID 17335315 DOI: 10.4088/Jcp.V68N0202  0.579
2006 McGrath PJ, Stewart JW, Quitkin FM, Chen Y, Alpert JE, Nierenberg AA, Fava M, Cheng J, Petkova E. Predictors of relapse in a prospective study of fluoxetine treatment of major depression. The American Journal of Psychiatry. 163: 1542-8. PMID 16946178 DOI: 10.1176/Appi.Ajp.163.9.1542  0.589
2006 Simpson HB, Huppert JD, Petkova E, Foa EB, Liebowitz MR. Response versus remission in obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 67: 269-76. PMID 16566623 DOI: 10.4088/Jcp.V67N0214  0.41
2005 Markowitz JC, Skodol AE, Petkova E, Xie H, Cheng J, Hellerstein DJ, Gunderson JG, Sanislow CA, Grilo CM, McGlashan TH. Longitudinal comparison of depressive personality disorder and dysthymic disorder. Comprehensive Psychiatry. 46: 239-45. PMID 16175753 DOI: 10.1016/J.Comppsych.2004.09.003  0.579
2005 Devlin MJ, Goldfein JA, Petkova E, Jiang H, Raizman PS, Wolk S, Mayer L, Carino J, Bellace D, Kamenetz C, Dobrow I, Walsh BT. Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder. Obesity Research. 13: 1077-88. PMID 15976151 DOI: 10.1038/Oby.2005.126  0.354
2005 McDowell D, Nunes EV, Seracini AM, Rothenberg J, Vosburg SK, Ma GJ, Petkova E. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial. Drug and Alcohol Dependence. 80: 209-21. PMID 15913920 DOI: 10.1016/J.Drugalcdep.2005.03.026  0.318
2004 Simpson HB, Liebowitz MR, Foa EB, Kozak MJ, Schmidt AB, Rowan V, Petkova E, Kjernisted K, Huppert JD, Franklin ME, Davies SO, Campeas R. Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorder. Depression and Anxiety. 19: 225-33. PMID 15274171 DOI: 10.1002/Da.20003  0.382
2003 Feinstein SB, Fallon BA, Petkova E, Liebowitz MR. Item-by-item factor analysis of the Yale-Brown Obsessive Compulsive Scale Symptom Checklist. The Journal of Neuropsychiatry and Clinical Neurosciences. 15: 187-93. PMID 12724460 DOI: 10.1176/Jnp.15.2.187  0.346
2003 Quitkin FM, Petkova E, McGrath PJ, Taylor B, Beasley C, Stewart J, Amsterdam J, Fava M, Rosenbaum J, Reimherr F, Fawcett J, Chen Y, Klein D. When should a trial of fluoxetine for major depression be declared failed? The American Journal of Psychiatry. 160: 734-40. PMID 12668363 DOI: 10.1176/Appi.Ajp.160.4.734  0.347
2003 Tarpey T, Petkova E, Ogden RT. Profiling Placebo Responders by Self-Consistent Partitioning of Functional Data Journal of the American Statistical Association. 98: 850-858. DOI: 10.1198/016214503000000783  0.342
2002 Bisaga K, Petkova E, Cheng J, Davies M, Feldman JF, Whitaker AH. Menstrual functioning and psychopathology in a county-wide population of high school girls. Journal of the American Academy of Child and Adolescent Psychiatry. 41: 1197-204. PMID 12364841 DOI: 10.1097/00004583-200210000-00009  0.544
2002 Lewis-Fernández R, Garrido-Castillo P, Bennasar MC, Parrilla EM, Laria AJ, Ma G, Petkova E. Dissociation, childhood trauma, and ataque de nervios among Puerto Rican psychiatric outpatients. The American Journal of Psychiatry. 159: 1603-5. PMID 12202287 DOI: 10.1176/Appi.Ajp.159.9.1603  0.339
2002 Blanco C, Petkova E, Ibáñez A, Sáiz-Ruiz J. A pilot placebo-controlled study of fluvoxamine for pathological gambling. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 14: 9-15. PMID 12046642 DOI: 10.1023/A:1015215809770  0.376
2000 McGrath PJ, Stewart JW, Petkova E, Quitkin FM, Amsterdam JD, Fawcett J, Reimherr FW, Rosenbaum JF, Beasley CM. Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression. The Journal of Clinical Psychiatry. 61: 518-24. PMID 10937611 DOI: 10.4088/Jcp.V61N0710  0.333
2000 Petkova E, Quitkin FM, McGrath PJ, Stewart JW, Klein DF. A method to quantify rater bias in antidepressant trials. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 559-65. PMID 10788756 DOI: 10.1016/S0893-133X(99)00154-2  0.335
2000 McGrath PJ, Stewart JW, Janal MN, Petkova E, Quitkin FM, Klein DF. A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression. The American Journal of Psychiatry. 157: 344-50. PMID 10698808 DOI: 10.1176/Appi.Ajp.157.3.344  0.325
1999 Wilson GT, Loeb KL, Walsh BT, Labouvie E, Petkova E, Liu X, Waternaux C. Psychological versus pharmacological treatments of bulimia nervosa: predictors and processes of change. Journal of Consulting and Clinical Psychology. 67: 451-9. PMID 10450615 DOI: 10.1037//0022-006x.67.4.451  0.348
1998 Quitkin FM, McGrath PJ, Stewart JW, Ocepek-Welikson K, Taylor BP, Nunes E, Delivannides D, Agosti V, Donovan SJ, Ross D, Petkova E, Klein DF. Placebo run-in period in studies of depressive disorders. Clinical, heuristic and research implications. The British Journal of Psychiatry : the Journal of Mental Science. 173: 242-8. PMID 9926101 DOI: 10.1192/Bjp.173.3.242  0.353
1996 Quitkein FM, McGrath PJ, Stewart JW, Ocepek-Welikson K, Taylor BP, Nunes E, Deliyannides D, Agosti V, Donovan SJ, Petkova E, Klein DF. Chronological milestones to guide drug change: When should clinicians switch antidepressants? Archives of General Psychiatry. 53: 785-792. PMID 8792755 DOI: 10.1001/Archpsyc.1996.01830090031005  0.308
Show low-probability matches.